参考文献/References:
[1] AL-OMARI A A,ALESHAWI A J,MAREI O A,et al.Avascular necrosis of the femoral head after single steroid intra-articular injection[J].Eur J Orthop Surg Traumatol,2020,30(2):193-197.
[2] WANG G,ZHANG L,YAN C,et al.Upregulation of microRNA-576-5p protects from steroid-induced avascular necrosis of the femoral head by suppressing ANXA2[J].Cell Cycle,2022,21(1):49-62.
[3] DE MARTINIS M,GINALDI L,ALLEGRA A,et al.The osteoporosis/microbiota linkage:the role of miRNA[J].Int J Mol Sci,2020,21(23):8887.
[4] 中国医师协会骨科医师分会骨循环与骨坏死专业委员会,中华医学会骨科分会骨显微修复学组,国际骨循环学会中国区.中国成人股骨头坏死临床诊疗指南(2020)[J].中华骨科杂志,2020,40(20):1365-1376.
[5] 中华医学会骨科学分会创伤骨科学组,中国医师协会骨科医师分会创伤专家工作委员会.成人股骨颈骨折诊治指南[J].中华创伤骨科杂志,2018,20(11):921-928.
[6] ZHAO X,ALQWBANI M,LUO Y,et al.Glucocorticoids decreased Cx43 expression in osteonecrosis of femoral head:the effect on proliferation and osteogenic differentiation of rat BMSCs[J].J Cell Mol Med,2021,25(1):484-498.
[7] ZHAO S R,WEN J J,MU H B.Role of Hsa-miR-122-3p in steroid-induced necrosis of femoral head[J].Eur Rev Med Pharmacol Sci,2019,23(3 Suppl):54-59.
[8] FANG S H,CHEN L,CHEN H H,et al.MiR-15b ameliorates SONFH by targeting Smad7 and inhibiting osteogenic differentiation of BMSCs[J].Eur Rev Med Pharmacol Sci,2019,23(22):9761-9771.
[9] GAO Y,PATIL S,QIAN A.The role of microRNAs in bone metabolism and disease[J].Int J MolSci,2020,21(17):6081.
[10] 徐丹,杨静华,朱世华,等.TGF-β、BMP-2及miR-672-5p与激素性股骨头坏死的关系分析[J].分子诊断与治疗杂志,2021,13(12):2013-2016.
[11] AHMAD N,KUSHWAHA P,KARVANDE A,et al.microRNA-672-5p identified during weaning reverses osteopenia and sarcopenia in ovariectomized mice[J].Mol Ther Nucleic Acids,2019,4:536-549.
[12] YANG W,ZHU W,YANG Y,et al.Exosomal miR-100-5p inhibits osteogenesis of hBMSCs and angiogenesis of HUVECs by suppressing the BMPR2/Smad1/5/9 signalling pathway[J].Stem Cell Res Ther,2021,12(1):390.
[13] 杨武,杨韵霏,郭民康,等.miR-100-5p通过抑制大鼠骨髓间充质干细胞的迁移和成骨分化参与非创伤性股骨头坏死[J].细胞与分子免疫学杂志,2022,38(2):159-164.
[14] TIAN L,SUN S,LI W,et al.Down-regulated microRNA-141 facilitates osteoblast activity and inhibits osteoclast activity to ameliorate osteonecrosis of the femoral head via up-regulating TGF-β2[J].Cell Cycle,2020,19(7):772-786.
[15] MENG C Y,XUE F,ZHAO Z Q,et al.Influence of microRNA-141 on inhibition of the proliferation of bone marrow mesenchymal stem cells in steroid-induced osteonecrosis via SOX11[J].Orthop Surg,2020,12(1):277-285.
[16] XUE F,WU J,FENG W,et al.microRNA141 inhibits the differentiation of bone marrow derived mesenchymal stem cells in steroidinduced osteonecrosis via E2F3[J].Mol Med Rep,2022,26(1):234.
[17] 田楠楠,冯蜜亚,吴涛.miR-141对股骨头坏死骨髓间质干细胞活性及VEGF/TGF-β2蛋白的影响[J].河北医学,2022,28(12):1949-1956.
[18] ZHANG W,ZHANG L,ZHOU Y,et al.Synergistic effects of BMP9 and miR-548d-5p on promoting osteogenic differentiation of mesenchymal stem cells[J].Biomed Res Int,2015:309747.
[19] DUAN P,WANG H,YI X,et al.C/EBPα regulates the fate of bone marrow mesenchymal stem cells and steroid-induced avascular necrosis of the femoral head by targeting the PPARγ signalling pathway[J].Stem Cell Res Ther,2022,13(1):342.
[20] SUN J,WANG Y,LI Y,et al.Down regulation of PPARγ by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potential[J].J Transl Med,2014,12:168.
[21] CHEN M,ZHOU M,FU Y,et al.Effects of miR-672 on the angiogenesis of adipose-derived mesenchymal stem cells during bone regeneration[J].Stem Cell Res Ther,2021,12(1):85.
[22] WANG T,ZHONG D,QIN Z,et al.miR-100-3p inhibits the adipogenic differentiation of hMSCs by targeting PIK3R1 via the Pl3K/AKT signaling pathway[J].Aging(Albany NY),2020,12(24):25090-25100.
[23] NAJM A,MASSON F M,PREUSS P,et al.microRNA-17-5p reduces inflammation and bone erosions in mice with collagen-induced arthritis and directly targets the JAK/STAT pathway in rheumatoid arthritis fibroblast-like synoviocytes[J].Arthritis Rheumatol,2020,72(12):2030-2039.
[24] WANG Y,HAN X,ZANG T,et al.miR-29b enhances the proliferation and migration of bone marrow mesenchymal stem cells in rats with castration-induced osteoporosis through the Pl3K/AKT and TGF-β/Smad signaling pathways[J].Exp Ther Med,2020,20(4):3185-3195.